DE602005027883D1 - 2-o, 3-o desulfatiertes heparin zur behandlung von heparininduzierter thrombozytopenie (hit) - Google Patents

2-o, 3-o desulfatiertes heparin zur behandlung von heparininduzierter thrombozytopenie (hit)

Info

Publication number
DE602005027883D1
DE602005027883D1 DE602005027883T DE602005027883T DE602005027883D1 DE 602005027883 D1 DE602005027883 D1 DE 602005027883D1 DE 602005027883 T DE602005027883 T DE 602005027883T DE 602005027883 T DE602005027883 T DE 602005027883T DE 602005027883 D1 DE602005027883 D1 DE 602005027883D1
Authority
DE
Germany
Prior art keywords
desulfated heparin
heparin
medicament
thrombocytopeny
heparine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005027883T
Other languages
German (de)
English (en)
Inventor
Jeanine M Walenga
Thomas Preston Kennedy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ParinGenix Inc
Original Assignee
ParinGenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ParinGenix Inc filed Critical ParinGenix Inc
Publication of DE602005027883D1 publication Critical patent/DE602005027883D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/727—Heparin; Heparan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
    • C08L5/10—Heparin; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
DE602005027883T 2004-10-27 2005-10-26 2-o, 3-o desulfatiertes heparin zur behandlung von heparininduzierter thrombozytopenie (hit) Expired - Lifetime DE602005027883D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/974,566 US7468358B2 (en) 2004-06-16 2004-10-27 Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome
PCT/US2005/039011 WO2006047755A2 (en) 2004-10-27 2005-10-26 Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (hit) syndrome

Publications (1)

Publication Number Publication Date
DE602005027883D1 true DE602005027883D1 (de) 2011-06-16

Family

ID=36228513

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005027883T Expired - Lifetime DE602005027883D1 (de) 2004-10-27 2005-10-26 2-o, 3-o desulfatiertes heparin zur behandlung von heparininduzierter thrombozytopenie (hit)

Country Status (9)

Country Link
US (1) US7468358B2 (cg-RX-API-DMAC7.html)
EP (1) EP1807095B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008518090A (cg-RX-API-DMAC7.html)
AT (1) ATE507836T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005299568A1 (cg-RX-API-DMAC7.html)
CA (1) CA2585640C (cg-RX-API-DMAC7.html)
DE (1) DE602005027883D1 (cg-RX-API-DMAC7.html)
ES (1) ES2366342T3 (cg-RX-API-DMAC7.html)
WO (1) WO2006047755A2 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050261241A1 (en) * 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
WO2008106584A1 (en) * 2007-02-28 2008-09-04 Paringenix, Inc. O-desulfated heparins treating acute exacerbations of chronic obstructive pulmonary disease
WO2009015183A1 (en) * 2007-07-23 2009-01-29 University Of Utah Research Foundation Method for blocking ligation of the receptor for advanced glycation end-products (rage)
WO2009117677A2 (en) * 2008-03-21 2009-09-24 University Of Utah Research Foundation Methods for controlling intracellular calcium levels associated with an ischemic event
WO2011014793A2 (en) 2009-07-31 2011-02-03 Reliable Biopharmaceutical Corporation Process for preparing fondaparinux sodium and intermediates useful in the synthesis thereof
US8420790B2 (en) 2009-10-30 2013-04-16 Reliable Biopharmaceutical Corporation Efficient and scalable process for the manufacture of Fondaparinux sodium
DK3144325T3 (da) * 2010-09-14 2021-01-25 Univ Miyazaki Heparin med høj renhed og fremstillingsfremgangsmåde dertil
DK2646037T3 (en) * 2010-12-01 2019-03-04 Univ Australian National use of polyanions to inhibit the cytotoxic activity of histones in the treatment of sepsis
WO2013016181A1 (en) * 2011-07-22 2013-01-31 Paringenix, Inc. Compositions and methods for anti-coagulation
WO2013115817A1 (en) 2012-02-02 2013-08-08 Reliable Biopharmaceutical Corporation An efficient and scalable process for the manufacture of fondaparinux sodium
BR112014028094B1 (pt) 2012-05-09 2022-03-03 Cantex Pharmaceuticals, Inc Uso de um heparinoide interagindo com fator de plaqueta 4
AU2016234916A1 (en) * 2012-05-09 2016-11-17 Cantex Pharmaceuticals, Inc. Treatment of myelosuppression
US20170096549A1 (en) 2014-03-17 2017-04-06 Cantex Pharmaceuticals, Inc. Multivalent cation formulations of partially desulfated heparins
EP3258941A4 (en) 2015-02-17 2018-09-26 Cantex Pharmaceuticals, Inc. Treatment of cancers and hematopoietic stem cell disorders privileged by cxcl12-cxcr4 interaction
CN107430137B (zh) 2015-03-03 2020-11-20 美国控股实验室公司 用于测量样品中的血清素的方法和系统
CA3102284A1 (en) * 2018-06-03 2019-12-12 Glycomira Therapeutics, Inc. Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy
WO2022015794A1 (en) 2020-07-14 2022-01-20 Optimvia, Llc Methods for synthesizing non-anticoagulant heparan sulfate
GB202006960D0 (en) * 2020-05-12 2020-06-24 Aplagon Oy Therapeutic

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1164145B1 (en) * 1992-07-24 2007-12-05 Thomas P. Kennedy Non-anticoagulant desulfated heparins as medicaments
US5668118A (en) * 1992-07-24 1997-09-16 Cavalier Pharmaceuticals Method of synthesis of 2-O-desulfated Heparin and use thereof for inhibition of elastase and Cathepspin G
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
US5990097A (en) * 1996-07-29 1999-11-23 Cavalier Pharmaceuticals Methods of treating asthma with o-desulfated heparin
EP1128842B1 (en) * 1998-11-13 2006-03-15 Eli Lilly And Company Use of human protein c for the manufacture of a medicament for treating heparin-induced thrombocytopenia
WO2001019376A2 (en) 1999-09-13 2001-03-22 Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center METHOD OF INHIBITING NF-λB WITH HEPARIN, FOR TREATING CARDIOVASCULAR DISEASES AND INFLAMMATIONS
US6489311B1 (en) 2000-05-02 2002-12-03 Charlotte-Mecklenburg Hospital Authoirty Method for the prevention of apoptosis
WO2004050673A2 (en) 2002-11-27 2004-06-17 Massachusetts Institute Of Technology Methods for synthesizing polysaccharides
US20050261241A1 (en) * 2004-05-19 2005-11-24 Celsus Biopharmaceuticals, Inc. Use of dermatan sulfates and/or desulfated heparins to treat or prevent heparinoid-induced autoimmune responses
US20050282775A1 (en) * 2004-06-16 2005-12-22 Paringenix, Inc. Method and medicament for sulfated polysaccharide treatment of inflammation without inducing platelet activation and heparin-induced thrombocytopenia syndrome

Also Published As

Publication number Publication date
CA2585640A1 (en) 2006-05-04
CA2585640C (en) 2012-01-10
EP1807095B1 (en) 2011-05-04
US20070123489A1 (en) 2007-05-31
US7468358B2 (en) 2008-12-23
AU2005299568A1 (en) 2006-05-04
WO2006047755A2 (en) 2006-05-04
JP2008518090A (ja) 2008-05-29
EP1807095A2 (en) 2007-07-18
ATE507836T1 (de) 2011-05-15
WO2006047755A3 (en) 2007-02-01
ES2366342T3 (es) 2011-10-19
EP1807095A4 (en) 2008-08-27

Similar Documents

Publication Publication Date Title
ATE507836T1 (de) 2-o, 3-o desulfatiertes heparin zur behandlung von heparininduzierter thrombozytopenie (hit)
Kidane et al. Anticoagulant and antiplatelet agents: their clinical and device application (s) together with usages to engineer surfaces
Spiess Heparin: effects upon the glycocalyx and endothelial cells
WO2006023397A3 (en) Method and medicament for anticoagulation using a sulfated polysaccharide with enhanced anti-inflammatory activity
ATE478867T1 (de) Substituierte quinazolinone verbindungen
BR0010380A (pt) Método, composição farmacêutica, kit e uso de uma combinação para prevenção e tratamento de diversas disfunções tromboembólicas e métodos de tratamento de trombose em mamìferos
WO2005012364A3 (fr) Matrice complexe a usage biomedical
DK0981381T3 (da) Polyhydroxyalkanoater ti anvendelser in vivo
ATE308979T1 (de) Lipasehemmende polymere
UA100378C2 (uk) Полімерна композиція, спосіб її виготовлення, виріб, спосіб його виготовлення та спосіб формування, застосування, спосіб підвищення швидкості текучості розплаву суміші та спосіб зменшення технологічного циклу формування виробу
BR8304973A (pt) Mistura de polimero compativel
MY149505A (en) Hyaluronic acid binary mixtures and therapeutic use thereof
JP2008518090A5 (cg-RX-API-DMAC7.html)
CA2311670A1 (en) Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions
ATE359798T1 (de) Verwendungvon dextransulfat zur behandlung von ibmir
Lee et al. Improved calcification resistance and biocompatibility of tissue patch grafted with sulfonated PEO or heparin after glutaraldehyde fixation
DK1284994T3 (da) Anvendelse af et ekstracellulært hæmoglobin med höj molekylvægt som blodsubstitut
BR112021010615A2 (pt) Clazakizumab no tratamento de rejeição crônica de transplante de órgãos mediada por anticorpos
IL165807A0 (en) Process for preparing epimerized derivatives of k5polysaccharide with a very high degree of sulfati on and new epi k5-n,o-sulfated polysaccharide derivatives
RU95104184A (ru) Антикоагулянт
DE60323973D1 (de) Verwendung von glykosaminglykanen wie z.b. heparin zur behandlung von atemerkrankungen wie copd
CA2434393A1 (en) Heparin with average molecular mass
WO2001015654A3 (fr) Polysaccharide antithrombotique de bas poids moleculaire
BRPI0510780A (pt) partìcula de polìmero enxertada com polissacarìdeo, uso da mesma, composição para tratamento em lavagem de roupas, uso de uma composição para tratamento de roupas, e, método para tratar tecido
EP1896511A4 (en) PROCESS FOR THE PREPARATION OF LOW MOLECULAR WEIGHT AND SALT POLYSACCHARIDE THEREFOR